Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Phathom Pharmaceuticals, Inc.(PHAT) | 7,464,572 | 7,464,572 | 0 | $80.99M | $54.49M | 43.02% | -$26.50M |
| Newamsterdam Pharma Company ORDINARY SHARES | 2,208,639 | 2,182,339 | -26,300 | $74.85M | $53.07M | 41.90% | -$21.78M |
| Aura Biosciences, Inc.(AURA) | 3,039,892 | 3,039,892 | 0 | $21.58M | $19.09M | 15.07% | -$2.49M |